Skip to main content
. Author manuscript; available in PMC: 2008 Oct 1.
Published in final edited form as: Am J Med. 2007 Apr 16;120(10):911.e9–911.15. doi: 10.1016/j.amjmed.2006.07.044

Table 3.

Clinical and laboratory spectrum of thiazide-associated hypercalcemia among Olmsted County, Minnesota, residents, 1992-2001, overall and subset later found to have primary hyperparathyroidism

Characteristic All patients mean ± SD, or n (%) Primary Hyperparathyroidism subset mean ± SD, or n (%)
Female gender 68 (94.4) 19 (95.0)
Age at onset of hypercalcemia, yrs 63.9 ± 11.3 66.2 ± 11.2
Serum calcium prior to thiazide use, mg/dL 9.7 ± 0.4 9.7 ± 0.5
Maximum serum calcium on thiazides, mg/dL 10.7 ± 0.3 11.0 ± 0.4
Serum parathyroid hormone, pmol/L 4.8 ± 2.7 6.3 ± 4.4
Years from thiazide start to hypercalcemia 6.0 ± 7.2 7.3 ± 8.5
Reason for thiazide use
 Hypertension 68 (94.4) 20 (100)
 Edema 2 (2.8) 0 (0)
 Hypercalciuria/nephrolithiasis 2 (2.8) 0 (0)